18F-FDG PET in sarcoma treatment response imaging

Authors:

  • 1 January 2011
    • journal article
    • review article
Abstract
Sarcomas are a biologically complex group of diseases that exhibit variable responses to single or combination therapy. F-18-FDG PET imaging contributes to sarcoma treatment response assessment as an objective semi-quantitative biomarker of response. In this review, background and experience in F-18-FDG PET as a biomarker that successfully identifies tumor response is assessed.

This publication has 35 references indexed in Scilit: